0001415889-22-012505.txt : 20221213
0001415889-22-012505.hdr.sgml : 20221213
20221213172522
ACCESSION NUMBER: 0001415889-22-012505
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221209
FILED AS OF DATE: 20221213
DATE AS OF CHANGE: 20221213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fernandes Peter
CENTRAL INDEX KEY: 0001642618
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36845
FILM NUMBER: 221460521
MAIL ADDRESS:
STREET 1: PERRYVILLE III CORPORATE PARK
STREET 2: 53 FRONTAGE ROAD, SUITE 301
CITY: HAMPTON
STATE: NJ
ZIP: 08827
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc.
CENTRAL INDEX KEY: 0001600132
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473116175
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302
CITY: WARREN
STATE: NJ
ZIP: 07059
BUSINESS PHONE: 908-574-4770
MAIL ADDRESS:
STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302
CITY: WARREN
STATE: NJ
ZIP: 07059
FORMER COMPANY:
FORMER CONFORMED NAME: Bellerophon Therapeutics LLC
DATE OF NAME CHANGE: 20140213
4
1
form4-12132022_051211.xml
X0306
4
2022-12-09
0001600132
Bellerophon Therapeutics, Inc.
BLPH
0001642618
Fernandes Peter
184 LIBERTY CORNER RD.
SUITE 302
WARREN
NJ
07059
false
true
false
false
PRINCIPAL EXECUTIVE OFFICER
Common Stock
2022-12-09
4
M
0
32500
A
32500
D
Common Stock
2022-12-09
4
F
0
9985
0.9301
D
22515
D
Restricted Stock Units
2022-12-09
4
M
0
32500
0
D
Common Stock
32500
32500
D
Each restricted stock unit represents the contingent right to receive, upon vesting of the unit, one share of Bellerophon common stock.
On January 26, 2022, the reporting person was granted 65,000 restricted stock units, 50% vesting on December 9, 2022 and 50% vesting on December 8, 2023, as long as the reporting person remains in the service of Bellerophon through the respective vesting date.
/s/ Peter Fernandes
2022-12-13